NCT03769441View on ClinicalTrials.gov

Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation

PHASE3CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

August 2, 2019

Primary Completion Date

August 19, 2024

Study Completion Date

August 19, 2024

Conditions
Iron-deficiencyTransplant-Related Disorder
Interventions
DRUG

Ferric carboxymaltose

Four intravenous dosages of ferric(III) carboxymaltose

DRUG

Sodium chloride

Four intravenous dosages of sodiumchloride

Trial Locations (2)

9713 GZ

University Medical Center Groningen, Groningen

Unknown

University Medical Center Utrecht, Utrecht

All Listed Sponsors
collaborator

Dutch Kidney Foundation

OTHER

collaborator

Vifor Fresenius Medical Care Renal Pharma

INDUSTRY

lead

University Medical Center Groningen

OTHER

NCT03769441 - Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation | Biotech Hunter | Biotech Hunter